Lilium N.V., a company incorporated in the Netherlands, has filed Pre-Effective Amendment No. 1 to its Form F-3 registration statement with the U.S. Securities and Exchange Commission (SEC) on August 2, 2024. This amendment is a follow-up to the original registration filed on July 29, 2024, under the registration number 333-281066. The purpose of this amendment is to update the Calculation of Filing Fee Tables, which is included as Exhibit 107 in the registration statement. The prospectus included in the original registration statement remains unchanged and is not part of this amendment. Lilium N.V. has indicated that the proposed sale of securities to the public will occur from time to time after the effective date of the registration statement. The company has...Show More

Lilium N.V., a company incorporated in the Netherlands, has filed Pre-Effective Amendment No. 1 to its Form F-3 registration statement with the U.S. Securities and Exchange Commission (SEC) on August 2, 2024. This amendment is a follow-up to the original registration filed on July 29, 2024, under the registration number 333-281066. The purpose of this amendment is to update the Calculation of Filing Fee Tables, which is included as Exhibit 107 in the registration statement. The prospectus included in the original registration statement remains unchanged and is not part of this amendment. Lilium N.V. has indicated that the proposed sale of securities to the public will occur from time to time after the effective date of the registration statement. The company has also checked the box indicating that the securities may be offered on a delayed or continuous basis under Rule 415 of the Securities Act of 1933. Lilium N.V. has been identified as an emerging growth company and has provided details regarding the indemnification of its directors and officers as per Dutch law and its articles of association. The company has entered into indemnification agreements with each of its directors and executive officers, although it acknowledges that indemnification for liabilities under the Securities Act may be unenforceable as it is against public policy.